Diurnal Ramadan Fasting on Appetite Hormone and Metabolic Profile Among Lean, Obesity, Diabetics
Department of Nutrition Science, Medical Faculty, Universitas Diponegoro, Semarang, Indonesia
1 other identifier
interventional
45
1 country
1
Brief Summary
Diabetes Mellitus individuals are known to have dietary rules, namely regulating the amount, type and time of eating. Ramadan fasting seems to be beneficial for people who want to reduce their weight, but it is not easy for diabetic patients. Because of its distinctive features, Ramadhan induces changes in eating habits, calorie consumption, sleeping patterns, and daily physical activity, which may contribute to changes in hunger-satiety responses and glicemic control. Examining changes in gut hormones during Ramadan fasting may reveal whether this observance could change glucose metabolism in diabetics without triggering the undesirable effect of gluconeogenesis. The proportions of fat, protein, and carbohydrate in meals vary between outside and within Ramadan. Alterations in timing and composition meal during Ramadan lead to reduced food intake may affect gut hormones and metabolic responses. The aim of this study to determine whether the effect of Ramadan fasting differed in people with DM patients, pre-DM and healthy individuals, with respect to gut hormones, body composition, metabolic parameters, and glycemic control
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 12, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2021
CompletedFirst Submitted
Initial submission to the registry
June 6, 2021
CompletedFirst Posted
Study publicly available on registry
June 11, 2021
CompletedJune 29, 2021
June 1, 2021
1 month
June 6, 2021
June 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
change acylated ghrelin
Change from Baseline acyl ghrelin at 30 days taken in the lab from venous blood specimen
30 days
change PYY
Change from Baseline PYY at 30 days taken in the lab from venous blood specimen
30 days
change GLP-1
Change from Baseline GLP-1 at 30 days taken in the lab from venous blood specimen
30 days
change insulin
Change from Baseline Insulin at 30 days taken in the lab from venous blood specimen
30 days
Secondary Outcomes (1)
change body weight
30 days
Study Arms (3)
lean ramadan fasting
EXPERIMENTALconduct ramadan fasting for 30 days
obese ramadan fasting
EXPERIMENTALconduct ramadan fasting for 30 days
diabetics ramadan fasting
EXPERIMENTALconduct ramadan fasting for 30 days
Interventions
subject conduct fasting in Ramadan for 30 days
Eligibility Criteria
You may qualify if:
- Diabetics subjects: glucose fasting plasma \> 200 mg/dL, with aged 35-60 years and body mass index above 25 kg/m;
- Obese subjects: body mass index above 25 kg/m2 with aged 35-60 years and waist circumference for men \>90 cm, for women \> 80 cm
- Lean subjects: body mass index below 23.5 kg/m2 with aged 35-60 years and waist circumference for men \<90 cm, for women \< 80 cm
You may not qualify if:
- experienced weight loss more than 10% from the actual weight in the last three months
- consumed medicine or supplement for weight loss diet, •. had the history of evidence of clinical depression, cognitive disorders, heart disease, cancer, liver or renal disease, chronic pulmonary disease, uncontrolled hypertension, physical disability, or other contraindications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Etika Ratna Noer
Semarang, Central Java, 50275, Indonesia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Etika R Noer
Diponegoro University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- subject with random allocation Investigator do not know the group the analysator do not know the group
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department of Nutrition, Medical Faculty
Study Record Dates
First Submitted
June 6, 2021
First Posted
June 11, 2021
Study Start
March 1, 2021
Primary Completion
April 12, 2021
Study Completion
May 1, 2021
Last Updated
June 29, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- anytime
- Access Criteria
- etikaratna@fk.undip.ac.id
the result of this study is available to cite everyone